Central regions | Technology & innovation

Russians move inch closer to solving cardiac arrhythmia problem

22 Apr '16
Russian biologists and physicists have developed technology enabling cardiac cell control with a laser. This is expected to pave the way for creating future solutions that may help rectify cardiac tissue excitability in arrhythmia cases, the Russian news agency RIA Novosti , citing a in PLoS One.

“The current result may be very useful for clinical trial testing of heart functionality mechanisms. In the future, we might learn to be able to counter arrhythmia attacks by simply pressing a button,” said Konstantin Agladze, the key author of the article and a researcher at Moscow’s MIPT, or Phystech.

Mr. Agladze and his colleagues from this top technology university are working to create a method of growing artificial cardiac tissue and be able to control its operation. The muscle tissue growth stage is over; now the researchers are looking for ways of sensitizing it at will. They once began the research in Kyoto in partnership with their Japanese colleagues, but it’s only now and at MIPT that the effort has borne fruit.

The Russians and Japanese found that heartbeat can be controlled using a special substance called azoTAB (azobenzene trimethylammonium bromide). This aromatic compound, or arene, can exist in two forms, the scientists discovered. One has no impact on the way the cardiac muscle works; the other suppresses heartbeat.

The MIPT researchers are reported to have used a UV spectrum laser to “switch” azoTAB from one of its forms to the other, thus making it possible to control cardiac muscle contraction in various points of its surface area by exposing some specific parts of the surface to UV beams.

As the scientists further found, the substance does not block cardiac cells irrevocably; it can be easily removed from cardiomyocyte monolayers, thus getting the monolayers to work the way they did before azoTAB was added. The MIPT researchers believe this opens opportunities for clinical research in an effort to develop effective arrhythmia therapies.
Find Related Content

Locations: Moscow

Tags: laser (46) / MIPT (35) / arrhythmia (1) / cardiac cell (0) / azoTAB (0) / Konstantin Agladze (0) /

Latest News: Central regions
16 Mar '17 | Technology & innovation | Finance, business

Sberbank and Moscow university team up in big data and machine learning

14 Mar '17 | Farming, agriculture | Technology & innovation

Internet of Things coming to Russian farms?

13 Mar '17 | Technology & innovation | Telecoms, media

Russia to draft new Code to regulate digital economy

10 Mar '17 | Technology & innovation

Software pinpoints culprit by odd walking

3 Mar '17 | Finance, business | Technology & innovation

Russians out, Intel in: state firms “gainfully” exit innovative CPU developer


Feature stories

6 Mar '17

Russian scientists blaze their own trail to light-based computing

Developing a photonic computer, a technology that...
25 Jan '17

Volga developer enables people to take good care of their heart

ScreenCardio-NN, an innovative company based in...
7 Dec '16

Research on Russian VC market: not quite bubbly, but far from moribund

In spite of all current problems and adverse external...
Search (News archive - 21049)
Nano & Giga Symposium
Report: Russian universities should modernize to compete globally
ITMO University

Latest News

17 Mar '17

New material helps use light to record data

At the ITMO University, scientists have created a...
16 Mar '17

Sberbank and Moscow university team up in big data and machine learning

Sberbank, Russia’s largest savings bank, and experts...
15 Mar '17

Siberian georadar to look for road defects in real time

Siberian scientists are working on software for...

Most read stories from last week

17 Mar '17

New material helps use light to record data

At the ITMO University, scientists have created a...